Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer
Authors:
- Hisato KawakamiHKHisato Kawakami
- Isamu OkamotoIOIsamu Okamoto
- Hidetoshi HayashiHHHidetoshi Hayashi
- Masataka TaguriMTMasataka Taguri
- Satoshi MoritaSMSatoshi Morita
- Kazuhiko NakagawaKNKazuhiko Nakagawa
- 1 September 2013
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 49 (14) , 3003-3009
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III StudyJournal of Clinical Oncology, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS TrialJournal of Clinical Oncology, 2010
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trialAnnals of Oncology, 2009
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerNew England Journal of Medicine, 2008
- Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study GroupJournal of Clinical Oncology, 2006
- Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerBritish Journal of Cancer, 1995
- Initial or delayed chemotherapy with best supportive care in advanced gastric cancerAnnals of Oncology, 1994
- Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancerCancer, 1993